Healthcare and biotech stocks were great recession-proof plays
in 2009, and still remain strong investment opportunities in 2011.
That's because even though consumer spending can get eroded by
expensive gas prices or unemployment fears, Americans will never
stop going to the doctor or paying for life-saving drugs and
That's why I frequently look at cheap, small-cap investment
opportunities in the healthcare, pharmaceutical and biotech
sectors. And I've got 10 great health care penny stocks for you to
consider buying today.
Now, the names on this healthcare and biotech penny stocks list
aren't true "
." That's because micro-cap pink sheet or OTC picks are way too
risky, and even though they cost only a few cents per share they
can cost you a fortune by wiping out your nest egg overnight. This
list of 10 cheap investments are a little bigger, and therefore a
little safer, but they still have the ability to continue
delivering spectacular gains.
Here are the 10 healthcare picks I suggest you investigate as
Dynavax Technologies Corp:
Dynavax Technologies Corp
) is known for developing products to prevent and treat infectious
diseases, asthma, and inflammatory and autoimmune diseases. In the
last six months, this penny stock is up +35%, compared to a gain of
+13% for the Dow Jones Industrial Average. Buy this penny stock
within its 52-week range of $1.58 to $3.59.
: Get the
Top Penny Stock Tips
AVI BioPharma Inc:
Specializing in ribonucleic acid (RNA) based drugs,
AVI BioPharma Inc.
) is about flat in the last 30 days but has almost doubled the
market with +23% gains in the last 12 months. Shareholders are also
pointing towards the 1,086% quarterly revenue growth from AVII's
last income statement. There may be even better times ahead for
AVII in 2011.
Another biopharmaceutical company worth looking at is
), because of its 7% rise in the last two months and strong
outlook. Potential investors are also noting the penny stock's
quarterly revenue growth of 26% year-over-year.
Opko Health Inc:
Vaccine and diagnostic technology producer
Opko Health Inc.
) has shown impressive gains of +70% in the last year. Another
statistic worth noting is OPK's quarterly revenue growth of 99%,
Known for treating patients with cancer, pharmaceutical company
) has watched its stock value increase 7% in the last two months.
Last quarter, this penny stock also posted a net profit margin
+32%. Buy near its 52-week high of $3.26.
Hansen Medical Inc:
Hansen Medical Inc.
) is up +73% compared to about +9% gains by the broader markets.
This company, which produces and sell medical robotics, also posted
a quarterly revenue growth of +95% in its last income statement.
Endoscopy related company
) has climbed +133% in the last 12 months, and +71% since the start
of 2011. In its last income statement, VSCI also posted a quarterly
revenue growth of 4%.
Avanir Pharmaceuticals Inc:
Developing products for the treatment of central nervous system
) has watched its stock gain +3% year-to-date and +52% since last
May. This penny stock should be purchased as it trades at three
times its 52-week low of $1.31.
Pfizer Has Lead in Cancer Drug Race
Columbia Laboratories Inc:
) has been the biggest gainer on this list, having jumped +195% in
the last 12 months. More recently, this penny stock is also up an
impressive +41% since January. Buy this stock with a 52-week range
of 88 cents to $4.31.
China Pharma Holdings Inc:
China Pharma Holdings Inc.
) posted a net profit margin of 35%. Additionally, the penny stock
has gained +7% in the last 30 days alone. A quarterly earnings
growth of +37% is another reason to purchase CPHI stock now.
As of this writing, Louis Navellier did not own a position in
any of the stocks named here.